Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikos Maniadakis

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|March 31, 2009
Analysis of published economic evaluations of angiotensin receptor blockersDorina Theodoratou, Nikos Maniadakis, Vasilis Fragoulakis, et al.
Pharmacoeconomics - Open|May 22, 2019
An Evaluation of Diagnosis-Related Group (DRG) Implementation Focused on Cancer DRGs in Greek Public HospitalsPanos Panagiotopoulos, Nikos Maniadakis, George Papatheodoridis, et al.
Cost Effectiveness and Resource Allocation : C/E|February 12, 2014
Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in GreeceGeorgia Kourlaba, Nikos Maniadakis, George Andrikopoulos, et al.
Clinical Drug Investigation|May 26, 2016
Cost-Effectiveness of Dapagliflozin as Add-On to Metformin for the Treatment of Type 2 Diabetes Mellitus in GreeceCharalampos Tzanetakos, Nicholas Tentolouris, Georgia Kourlaba, et al.
European Journal of Public Health|July 27, 2010
Factors associated with the use of preventive services by women in GreeceEffie Simou, Emanouel Foundoulakis, Georgia Kourlaba, et al.
Current Medical Research and Opinion|February 14, 2009
XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysisNikos Maniadakis, Vasilios Fragoulakis, Dimitrios Pectasides, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Pharmacoeconomic considerations in the treatment of breast cancerAthanasios Pallis, Vasiliki Tsiantou, Efi Simou, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 27, 2011
Health technology assessment: what is it? Current status and perspectives in the field of electrophysiologyGiovanni Fattore, Nikos Maniadakis, Lorenzo G Mantovani, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 23, 2010
Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in GreeceNikos Maniadakis, Mattias Ekman, Vasilios Fragoulakis, et al.
Current Medical Research and Opinion|July 28, 2006
Economic evaluation of tiotropium and salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) in GreeceNikos Maniadakis, Nikolaos Tzanakis, Vassilis Fragoulakis, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|March 31, 2009
Analysis of published economic evaluations of angiotensin receptor blockersDorina Theodoratou, Nikos Maniadakis, Vasilis Fragoulakis, et al.
Pharmacoeconomics - Open|May 22, 2019
An Evaluation of Diagnosis-Related Group (DRG) Implementation Focused on Cancer DRGs in Greek Public HospitalsPanos Panagiotopoulos, Nikos Maniadakis, George Papatheodoridis, et al.
Cost Effectiveness and Resource Allocation : C/E|February 12, 2014
Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in GreeceGeorgia Kourlaba, Nikos Maniadakis, George Andrikopoulos, et al.
Clinical Drug Investigation|May 26, 2016
Cost-Effectiveness of Dapagliflozin as Add-On to Metformin for the Treatment of Type 2 Diabetes Mellitus in GreeceCharalampos Tzanetakos, Nicholas Tentolouris, Georgia Kourlaba, et al.
European Journal of Public Health|July 27, 2010
Factors associated with the use of preventive services by women in GreeceEffie Simou, Emanouel Foundoulakis, Georgia Kourlaba, et al.
Current Medical Research and Opinion|February 14, 2009
XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysisNikos Maniadakis, Vasilios Fragoulakis, Dimitrios Pectasides, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Pharmacoeconomic considerations in the treatment of breast cancerAthanasios Pallis, Vasiliki Tsiantou, Efi Simou, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 27, 2011
Health technology assessment: what is it? Current status and perspectives in the field of electrophysiologyGiovanni Fattore, Nikos Maniadakis, Lorenzo G Mantovani, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 23, 2010
Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in GreeceNikos Maniadakis, Mattias Ekman, Vasilios Fragoulakis, et al.
Current Medical Research and Opinion|July 28, 2006
Economic evaluation of tiotropium and salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) in GreeceNikos Maniadakis, Nikolaos Tzanakis, Vassilis Fragoulakis, et al.
Pageof 7